MEDINCELL SA (MEDCL.PA) Stock Income Statement
EPA:MEDCL - Euronext Paris - Matif - FR0004065605 - Common Stock - Currency: EUR
| TTM (2024-9-30) | 2025 (2025-3-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 10.67M | 25.42M | 9.03M | 9.89M | 4.09M | |||
| Minority Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | 896.00K | N/A | 2.27M | 3.43M | 1.50M | |||
| Gross Profit | 9.77M | N/A | 6.77M | 6.46M | 2.59M | |||
| Operating Expenses | 29.16M | 36.26M | 27.61M | 30.51M | 26.40M | |||
| Research and Development | 18.03M | 24.31M | 17.51M | 23.23M | 20.91M | |||
| Selling, General, and Administrative Expenses | 12.30M | 14.18M | 11.42M | 9.38M | 8.26M | |||
| Operating Income | -19.39M | -10.84M | -20.84M | -24.05M | -23.81M | |||
| Interest Income/Expense | -11.71M | -7.21M | -3.98M | -7.93M | -945.00K | |||
| Other Income/Expense | 3.00K | -230.00K | 9.00K | -36.00K | -47.00K | |||
| Non Recurring Items | N/A | N/A | -133.00K | 6.00K | N/A | |||
| Income Before Taxes | -31.23M | -18.28M | -24.95M | -32.01M | -24.81M | |||
| Income Tax | 217.00K | 160.00K | 88.00K | 0.00 | 0.00 | |||
| Net Income | -31.45M | -18.44M | -25.04M | -32.01M | -24.81M | |||
| EBITDA | -17.70M | N/A | -19.13M | -22.39M | -22.30M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.08 | -0.63 | -0.88 | -1.27 | -1.00 | |||
| Statistics | ||||||||
| Gross Profit Margin | 91.60% | N/A | 74.92% | 65.28% | 63.23% | |||
| Profit Margin | -294.82% | -72.54% | -277.21% | -323.69% | -606.50% | |||
| Operating Profit Margin | -181.79% | -42.65% | -230.78% | -243.22% | -582.25% | |||
All data in EUR